Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-06-04 00:00:00 ET · period of report 2025-06-02 · accession 0001765581-25-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-04 | 2025-06-02+ | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale | $108.95 | -1,000 | 438.5K | -0.2% | -$109.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-06-03 | S | D | 500 | $110.00 | 437,973 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-06-02 | S | D | 500 | $107.90 | 438,473 | D | — | — | (F2) The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025. |